Study guide

14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool

Philippine Medical Technologists Licensure Examination MTLE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Clinical Chemistry: Laboratory Operations, Instrumentation, Reagents, Quality Assurance, and Safety

1.1 Specimen Collection, Preanalytical Variables, and Interferences 1.2 Clinical Chemistry Instrumentation, Photometry, and Automation 1.3 Quality Control, Westgard Rules, Calibration, and Laboratory Mathematics 1.4 Reagent Preparation, Laboratory Water, Glassware, Pipettes, and Centrifuges 1.5 Laboratory Safety: Chemical, Fire, Electrical, Biological, and Physical Hazards

2 Chapter 2: Clinical Chemistry: Carbohydrates, Lipids, Proteins, Non-Protein Nitrogen, and Liver Function

2.1 Glucose Homeostasis, Diagnostic Criteria for Diabetes Mellitus, and Glycemic Monitoring 2.2 Lipids, Lipoproteins, Apolipoproteins, and Coronary Heart Disease Risk Assessment 2.3 Serum Proteins, Albumin, Globulins, and Serum Protein Electrophoresis Patterns 2.4 Non-Protein Nitrogen Compounds: Urea, Creatinine, Uric Acid, and Renal Function 2.5 Liver Function Tests, Bilirubin Metabolism, and Jaundice

3 Chapter 3: Clinical Chemistry: Electrolytes, Blood Gases, Enzymology, Endocrinology, and Toxicology

3.1 Water Balance, Electrolytes, Osmolality, and Anion Gap Calculations 3.2 Blood Gas Analysis, Oxygenation, and Acid-Base Homeostasis 3.3 Clinical Enzymology: Enzyme Kinetics, Cardiac Biomarkers, and Hepatic and Pancreatic Enzymes 3.4 Endocrinology: Hormone Physiology and Endocrine Function Testing 3.5 Therapeutic Drug Monitoring and Clinical Toxicology

4 Chapter 4: Bacteriology: Specimen Management, Media, Staining, and Biosafety

4.1 Specimen Collection, Transport, Processing, and Microscopic Staining 4.2 Culture Media Classification, Quality Control, and Inoculation Techniques 4.3 Sterilization, Disinfection, Decontamination, and Biosafety Containment 4.4 Antimicrobial Susceptibility Testing Methods, Standardization, and Resistance Mechanisms

5 Chapter 5: Diagnostic Bacteriology: Major Pathogenic Bacteria

5.1 Medically Important Gram-Positive Cocci: Staphylococci, Streptococci, and Enterococci 5.2 Medically Important Gram-Negative Bacilli: Enterobacterales and Non-Fermenters 5.3 Fastidious, Microaerophilic, and Anaerobic Bacteria 5.4 Mycobacteria, Spirochetes, Atypical Bacteria, and Public Health Microbiology

6 Chapter 6: Medical Parasitology, Mycology, and Diagnostic Virology

6.1 Stool Examination Techniques and Intestinal Nematodes 6.2 Tissue Nematodes, Filarial Worms, Cestodes, and Trematodes 6.3 Medical Protozoology: Intestinal, Urogenital, and Blood/Tissue Protozoa 6.4 Medical Mycology: Yeasts, Dermatophytes, Dimorphic Fungi, and Opportunistic Molds 6.5 Clinical Virology: Viral Structure, Specimen Handling, and Diagnostic Methods

7 Chapter 7: Hematology: Specimen Collection, Routine Parameters, Instrumentation, and Manual Methods

7.1 Blood Specimen Collection, Anticoagulants, Preanalytical Variables, and Specimen Quality 7.2 Automated Cell Counting Principles, Complete Blood Count Parameters, and Erythrocyte Indices 7.3 Reticulocyte Evaluation, Supravital Staining, and Erythrocyte Sedimentation Rate 7.4 Manual Cell Counts, Manual Hemoglobin Methods, and Hematology Quality Control

8 Chapter 8: Hematology: Blood Cell Morphology, Bone Marrow, and Hematologic Disorders

8.1 Normal Erythropoiesis and Erythrocyte Morphologic Abnormalities 8.2 Anemias: Classification, Iron Deficiency, Megaloblastic, Hemolytic, and Hemoglobinopathies 8.3 Normal Leukopoiesis, Leukocyte Differential, and Non-Malignant White Cell Alterations 8.4 Hematologic Malignancies: Acute and Chronic Leukemias, Myeloproliferative and Lymphoproliferative Disorders 8.5 Peripheral Blood Smear Preparation and Staining, Bone Marrow Examination, and Cytochemistry

9 Chapter 9: Hemostasis: Coagulation and Platelet Function Testing and Hemostatic Disorders

9.1 Mechanisms of Primary and Secondary Hemostasis, Fibrinolysis, and Natural Inhibitors 9.2 Coagulation Laboratory Testing: PT/INR, aPTT, Fibrinogen, Thrombin Time, and Mixing Studies 9.3 Hemostatic and Thrombotic Disorders: Hemophilias, von Willebrand Disease, DIC, and Thrombophilias 9.4 Bleeding Time, Clotting Time, Platelet Function, and Special Hematology Tests

10 Chapter 10: Immunohematology: Blood Group Systems and Antiglobulin Testing

10.1 The ABO Blood Group System, Genetics, Subgroups, and Forward/Reverse Typing Discrepancies 10.2 The Rh Blood Group System, Weak D Testing, and Other Major Blood Group Systems 10.3 Antiglobulin Testing, Elution, Adsorption, and Special Antibody Procedures

11 Chapter 11: Blood Banking: Donor Operations, Component Therapy, and Adverse Reactions

11.1 Donor Selection, Physical Examination, Screening, and Mandatory Infectious Marker Testing 11.2 Blood Component Preparation, Storage, Expiration, and Indications for Transfusion 11.3 Pre-Transfusion Compatibility Testing and Transfusion Reactions 11.4 Hemolytic Disease of the Fetus and Newborn (HDFN) and Rh Immune Globulin

12 Chapter 12: Clinical Serology and Immunology

12.1 Principles of Immunology: Antigens, Antibodies, Complement, and Immune Responses 12.2 Serologic Testing Methodologies: Agglutination, Precipitation, Flocculation, and Labeled Immunoassays 12.3 Infectious Disease Serology: Syphilis, Viral Hepatitis Markers, HIV, Dengue, and Febrile Agglutinins 12.4 Autoimmune Serology, Hypersensitivity, Immunodeficiencies, and Histocompatibility (HLA)

13 Chapter 13: Clinical Microscopy: Urinalysis and Renal Pathology

13.1 Renal Physiology, Urine Formation, and Physical Examination of Urine 13.2 Chemical Examination of Urine: Reagent Strip Principles, Interferences, and Confirmatory Tests 13.3 Microscopic Examination of Urine Sediment: Cells, Casts, Crystals, and Contaminants 13.4 Renal Calculi, Glomerular/Tubular/Interstitial Renal Diseases, and Urinalysis Quality Control

14 Chapter 14: Clinical Microscopy: Body Fluids, Fecal Analysis, and Gastric, Duodenal, and Respiratory Specimens

14.1 Cerebrospinal Fluid Analysis: Collection, Cell Counts, Chemistry, and Microbiology 14.2 Serous Fluids (Pleural, Pericardial, Peritoneal: Transudates vs Exudates) and Synovial Fluid Analysis 14.3 Seminal Fluid and Amniotic Fluid Analysis 14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool 14.5 Gastric Fluid, Duodenal Contents, Sputum, and Bronchoalveolar Specimens

15 Chapter 15: Histopathologic Techniques and Cytotechnology

15.1 Tissue Preservation, Fixation, Decalcification, and Processing Steps 15.2 Microtomy, Sectioning Artifacts, Hematoxylin and Eosin Staining, and Special Stains 15.3 Cytotechnology: Specimen Collection, Fixation, Papanicolaou Staining, and the Bethesda System 15.4 Special Procedures: Frozen Sections, Special Embedding, Immunohistochemistry, Electron Microscopy, Autopsy, Museum Techniques, and Laboratory Records

16 Chapter 16: Medical Technology Laws, Related Laws, and Ethics

16.1 Republic Act No. 5527 (The Philippine Medical Technology Act of 1969) and Key Amendments 16.2 Related Philippine Healthcare Laws, Code of Ethics, and Bioethics

14.4 Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool

Key Takeaways Explain This Topic AI

Liquid stool should be examined within 30 minutes and soft stool within 1 hour of passage, because trophozoites degenerate quickly.

Guaiac fecal occult blood tests detect heme pseudoperoxidase and need diet restrictions, while immunochemical tests detect human globin without diet restrictions.

Increased neutral fat on Sudan III staining points to pancreatic maldigestion, whereas increased split fat with normal neutral fat points to intestinal malabsorption.

In the APT test, fetal hemoglobin resists 1% sodium hydroxide and stays pink, while swallowed maternal hemoglobin turns yellow-brown.

Low fecal elastase-1 indicates exocrine pancreatic insufficiency, and raised fecal calprotectin indicates intestinal inflammation rather than irritable bowel syndrome.

Last updated: October 2026

Fecal Analysis: Macroscopic, Microscopic, and Chemical Examination of Stool

Feces carries 10% of the Clinical Microscopy blueprint, which is itself 10% of the MTLE. Routine fecalysis is one of the most frequently requested tests in Philippine laboratories, usually for diarrhea and parasite screening. Stool parasite techniques are covered in the parasitology sections. This section covers the rest of fecal analysis: collection, gross examination, occult blood testing, fat and meat-fiber screening, fecal leukocytes, carbohydrate testing, the APT test for swallowed maternal blood, and fecal enzyme and inflammation markers.

1. Specimen Collection and Normal Composition

Container: A clean, dry, leak-proof, wide-mouthed container. The specimen must not be contaminated with urine (which harms trophozoites and dilutes chemistry) or toilet water (which can add free-living organisms).

Timing for microscopy: Examine liquid stool within 30 minutes and soft stool within 1 hour of passage, because trophozoites lose motility and degenerate. Formed stool, which contains cysts and eggs, can wait up to 24 hours if refrigerated.

Quantitative tests: Fecal fat requires a timed collection (usually 72 hours) in a pre-weighed container while the patient eats about 100 g of fat per day.

Normal composition: An adult passes about 100 to 200 g of stool per day, roughly three-quarters water. The rest is bacteria, undigested cellulose, sloughed epithelial cells, bile pigments, and electrolytes.

2. Gross Examination, Occult Blood, Fecal Fat, and Fecal Leukocytes

Routine fecalysis evaluates digestive function, gastrointestinal bleeding, malabsorption, and intestinal infections.

Gross Stool Characteristics

Color: Normal brown color is generated by stercobilin and urobilin , oxidized products of the urobilinogens (stercobilinogen) that colonic bacteria form from conjugated bilirubin.

Acholic (Clay-colored / Pale Gray): Post-hepatic biliary obstruction (absence of bile pigments entering the duodenum) or barium sulfate ingestion.

Melena (Black, Tarry Stool): Upper gastrointestinal bleeding (> 50 to 100 mL of blood, e.g., bleeding peptic ulcer); hemoglobin is enzymatically digested into dark acid hematin.

Hematochezia (Bright Red Stool): Lower gastrointestinal bleeding (e.g., hemorrhoids, diverticular disease, ulcerative colitis, colorectal adenocarcinoma).

Ribbon-like / Pencil-shaped Stool: Distal colorectal lumen obstruction (annular carcinoma, stricture).

Rice-Water Stool: Watery fluid with epithelial flecks and mucus; classic for Vibrio cholerae enterotoxin infection.

Fecal Occult Blood Testing (FOBT)

Occult blood represents hidden blood not visually apparent upon gross inspection, utilized in population screening for colorectal carcinoma.

Loading diagram...

Guaiac-based FOBT (gFOBT, e.g., Hemoccult):

Chemical Principle: Relies on the pseudoperoxidase activity of heme in hemoglobin. Heme catalyzes the transfer of oxygen from hydrogen peroxide (H2O2) to phenolic gum guaiac (a colorless leuco-dye), oxidizing it into a brilliant blue-colored quinone compound .

Pre-Analytical Restrictions (3 Days Prior):

False-Positive Causes: Ingestion of red meat (bovine hemoglobin/myoglobin); foods rich in plant peroxidases (raw horseradish, turnips, broccoli, cantaloupe); aspirin and NSAIDs (inducing gastric micro-bleeding).

False-Negative Causes: Ascorbic acid (Vitamin C > 250 mg/day) , a powerful reducing agent that scavenges peroxide intermediates, preventing guaiac oxidation even in the presence of massive occult blood.

Immunochemical Fecal Occult Blood Test (iFOBT / Fecal Immunochemical Test [FIT]):

Analytical Principle: Utilizes monoclonal or polyclonal antibodies directed against the protein globin portion of intact human hemoglobin .

Advantages:

No dietary restrictions: Antibodies do not cross-react with animal hemoglobin, plant peroxidases, or dietary antioxidants like vitamin C.

High Specificity for Lower GI Bleeding: Globin released from upper gastrointestinal bleeding is digested and destroyed by gastric pepsin and pancreatic proteases before reaching the colon, rendering it non-reactive with FIT antibodies. Thus, FIT specifically flags colorectal pathology without interference from upper tract gastritis.

Fecal Fat Screening (Steatorrhea)

Normal adult fecal fat excretion is up to about 6 g/day on a standardized 100-g fat diet; higher outputs (commonly quoted as > 6 to 7 g/day) define steatorrhea , resulting from either pancreatic exocrine insufficiency (maldigestion) or small intestinal mucosal disease (malabsorption).

Qualitative Sudan III / Oil Red O Staining:

Neutral Fats (Triglycerides): Stool is emulsified with 95% ethanol and mixed directly with Sudan III dye. Neutral fats appear as large, spherical, refractile orange-red lipid droplets. Normal stool contains < 60 small droplets per high-power field (HPF). Presence of > 60 large droplets/HPF indicates neutral fat maldigestion (pancreatic lipase deficiency, as in chronic pancreatitis or cystic fibrosis).

Split Fats (Free Fatty Acids and Soaps): Stool is mixed with 36% glacial acetic acid and Sudan III, then heated to boiling. Acetic acid hydrolyzes fatty acid soaps into free fatty acids that coalesce into orange-red droplets upon cooling. Abundant split fats accompanied by normal neutral fats point to small intestinal mucosal malabsorption (e.g., celiac sprue, Crohn's disease) rather than pancreatic failure.

Quantitative Fecal Fat: Gold standard consists of a 72-hour stool collection with dietary fat standardization (100 g/day fat intake) analyzed via Van de Kamer titration .

Fecal Leukocytes

Evaluated on wet mount preparations stained with Loeffler's methylene blue or Gram stain.

Normal stool contains no leukocytes.

Positive Fecal Leukocytes (> 3 PMNs/HPF): Indicates mucosal-invasive or inflammatory bacterial colitis: Shigella , Salmonella enterica , Campylobacter jejuni , enteroinvasive E. coli (EIEC), Clostridioides difficile , and active ulcerative colitis.

Negative Fecal Leukocytes: Characteristic of toxin-mediated, non-invasive secretory diarrheas: enterotoxigenic E. coli (ETEC), Vibrio cholerae , Staphylococcus aureus enterotoxin, rotavirus, norovirus, and Giardia duodenalis .

Consistency and Mucus

Watery stool reflects secretory or osmotic diarrhea; bulky, frothy, foul-smelling, greasy stool that floats suggests steatorrhea.

Translucent mucus coating a formed stool suggests straining or spastic constipation. Mucus mixed with blood and pus suggests inflammatory or invasive colitis (shigellosis, amebic dysentery, ulcerative colitis).

3. Microscopic Examination for Digestion Products

Muscle (meat) fibers: A stool emulsion is stained with 10% eosin in alcohol, and undigested fibers show striations in both directions . More than 10 undigested fibers in a standard examination after a meat-containing diet indicates impaired protein digestion ( creatorrhea ), as in pancreatic insufficiency or cystic fibrosis.

Fat droplets: Sudan III screening for neutral fat and split fat is described above. Pancreatic insufficiency increases neutral fat; malabsorption increases split fat with normal neutral fat.

Starch granules (stained blue-black with iodine) suggest rapid transit or amylase deficiency, and vegetable cells and fibers are normal dietary residue.

  • 4. Chemical Tests Beyond Occult Blood
  • Fecal Carbohydrates

A copper reduction test (Clinitest tablet) on a 1:2 dilution of liquid stool detects reducing sugars. More than about 0.5 g/dL suggests carbohydrate malabsorption or intolerance, such as lactase deficiency. Sucrose is not a reducing sugar and is missed unless the specimen is first hydrolyzed.

Stool pH below about 5.5 suggests carbohydrate malabsorption, because colonic bacteria ferment unabsorbed sugars to organic acids.

The D-xylose absorption test separates small-bowel malabsorption (low blood and urine xylose) from pancreatic maldigestion (normal xylose, because xylose needs no pancreatic enzymes).

APT (Alkali-Denaturation) Test for Swallowed Maternal Blood

Used on bloody stool or vomitus of a newborn to decide whether the blood is the infant's (possible gastrointestinal bleeding) or maternal blood swallowed during delivery or breastfeeding.

The specimen is mixed with water and centrifuged, and the pink supernatant is mixed with 1% sodium hydroxide.

Fetal hemoglobin (HbF) resists alkali denaturation and stays pink. Adult hemoglobin (HbA) from the mother is denatured to alkaline hematin and turns yellow-brown within about 2 minutes.

The test requires fresh, pink (oxygenated) blood; black, tarry stool already contains denatured hemoglobin and cannot be tested.

Fecal Enzyme and Inflammation Markers

Fecal elastase-1: Measured by immunoassay. It is stable during intestinal transit, and low values (commonly below 200 µg/g of stool) indicate exocrine pancreatic insufficiency.

Fecal trypsin and chymotrypsin: Older screens for pancreatic insufficiency. The classic gelatin-film test detected trypsin by its digestion of the gelatin on x-ray film.

Fecal calprotectin and lactoferrin: Neutrophil proteins that rise in inflammatory bowel disease and invasive infections, but not in irritable bowel syndrome.

5. Fecal Analysis Summary

Test Principle Key Interpretation

Guaiac FOBT Pseudoperoxidase activity of heme oxidizes guaiac to a blue product False positives from red meat and plant peroxidases; false negatives from vitamin C

Immunochemical FOBT (FIT) Antibody to human globin No diet restriction; specific for lower gastrointestinal bleeding

Sudan III (neutral and split fat) Lipid-soluble dye stains fat orange-red More than 60 droplets per HPF suggests steatorrhea

Muscle fibers Eosin-stained undigested fibers More than 10 fibers with striations in both directions suggests pancreatic insufficiency

Fecal leukocytes Methylene blue or Gram stain More than 3 neutrophils per HPF suggests invasive bacterial colitis

Clinitest and stool pH Copper reduction; fermentation acids More than 0.5 g/dL reducing sugar or pH below 5.5 suggests carbohydrate malabsorption

  • APT test Alkali resistance of HbF Pink: fetal blood; yellow-brown: swallowed maternal blood
  • Fecal elastase-1 Immunoassay Low value indicates exocrine pancreatic insufficiency